Asia Pacific Medical Tubing Market
Published On: Mar 2025
Published On: Mar 2025
According to Business Market Insights’ research, the Asia Pacific medical tubing market was valued at US$ 3,310.33 million in 2023 and is expected to reach US$ 6,279.27 million by 2031, registering a CAGR of 8.3% from 2023 to 2031. Tubes with advanced features such as biocompatibility and antimicrobial properties and expanding applications in biopharmaceutical processing are among the critical factors attributed to drive the Asia Pacific medical tubing market growth.
The utilization of medical tubing is on the rise in the pharmaceutical and biopharmaceutical industries. Bioprocessing involves utilizing living cells or their components to produce desired products. This process requires specialized tubing solutions to ensure efficiency, safety, and adherence to strict regulatory standards. The purity of materials used is crucial in bioprocessing applications. Medical-grade tubing made from biocompatible materials such as silicone and thermoplastic elastomers (TPE) is essential to prevent the leaching of harmful substances into biopharmaceutical products. The increasing regulatory emphasis on product safety and efficacy drives the demand for medical tubing solutions that guarantee high levels of purity and biocompatibility during bioprocessing. Various market players are launching medical-grade tubing with applications in biopharmaceutical fluid processing. In October 2023, RAUMEDIC expanded its range of biopharmaceutical fluid processing products by introducing a new brand of biocompatible tubing. Its portfolio includes a diverse selection of biocompatible fluid processing tubing systems—SILMOTION (silicone tubing), BRAIDMOTION (braided silicone tubing), THERMMOTION (thermoplastic elastomer tubing), PVC tubing, and FEP tubing. Bioprocessing frequently involves transporting sensitive biological materials, necessitating specialized tubing that can withstand varying pressures and flow rates without compromising the integrity of the contents. Advanced medical tubing is also utilized for fluid transport in bioprocessing applications, improving the efficiency of biopharmaceutical manufacturing processes. In October 2021, DuPont introduced a new range of extruded pharmaceutical tubing made from TPE. The newly launched Liveo Pharma TPE Tubing products are designed for fluid transport and single-use bioprocessing applications, maintaining the high standards of the Liveo Silicone Pharma Tubing lines. The TPE tubing range of DuPont complements its existing silicone products while prioritizing quality, purity, and performance. Its benefits include improved heat welding, high tensile strength, burst resistance, minimal spallation after pumping, suitability for low extractable volumes, and good chemical resistance. This tubing is ideal for biopharma processing, enabling aseptic connections without the need for connectors; it is also suitable for peristaltic pump applications. Thus, expanding applications of medical tubing in bioprocessing, and fluid transport and handling applications propels the medical tubing market.
On the contrary, recalls due to product failure hamper the growth of Asia Pacific medical tubing market.
By type, the Asia Pacific medical tubing market is segmented into polyvinyl chloride (PVC), polyimide or nylons, PTFE or thermoplastic elastomers (TPES), thermoplastic polyurethanes (TPUS), polyvinylidene fluoride (PVDF), polypropylene and polyethylene, silicone, and others. The polyvinyl chloride (PVC) segment held 31.3% share of Asia Pacific medical tubing market share in 2023, amassing US$ 1,035.71 million. It is projected to garner US$ 1,940.02 million by 2031 to register 8.2% CAGR during 2023–2031.
In terms of structure, the Asia Pacific medical tubing market is segmented into single-lumen, multi-lumen, multi-layer extruded tubing, tapered or bump tubing, braided tubing, balloon tubing, corrugated tubing, heat shrink tubing, and others. The single-lumen segment held 19.8% share of Asia Pacific medical tubing market share in 2023, amassing US$ 657.05 million. It is projected to garner US$ 1,282.93 million by 2031 to register 8.7% CAGR during 2023–2031.
Based on application, the Asia Pacific medical tubing market is segmented into bulk disposable tubing, catheters and cannula, drug delivery systems, and others. The bulk disposable tubing segment held 34.0% share of Asia Pacific medical tubing market share in 2023, amassing US$ 1,126.80 million. It is projected to garner US$ 2,156.91 million by 2031 to register 8.5% CAGR during 2023–2031.
By end users, the Asia Pacific medical tubing market is segmented into hospital and clinics, ambulatory care centers, medical labs, and others. The hospital and clinics segment held 61.1% share of Asia Pacific medical tubing market share in 2023, amassing US$ 2,021.95 million. It is projected to garner US$ 3,802.73 million by 2031 to register 8.2% CAGR during 2023–2031.
Based on country, the Asia Pacific medical tubing market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 31.7% share of Asia Pacific medical tubing market in 2023. It was assessed at US$ 1,048.30 million in 2023 and is likely to hit US$ 1,976.18 million by 2031, registering a CAGR of 8.2% during 2023–2031.
Key players operating in the medical tubing market are Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD., among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
